Why You Should Still Hold Argos Therapeutics, Inc. (NASDAQ:ARGS) Stock Today

Argos Therapeutics, Inc. (NASDAQ:ARGS) fell by -2.80% in the last day from $0.30 to $0.29 and has now fallen 9 consecutive sessions. The price has fallen in 8 of the last 10 days and is down by -17.88% over the same course of time. There was a decrease in both volume and price. This is usually interpreted as a good sign as traders widely believe falling stock should see declining volume. Traded activity experienced a fall of -0.07 million shares and in total 1.11 M shares exchanged hands for about $322 678.

Inside ARGS’s Recent Trend

Argos Therapeutics, Inc. (ARGS) lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down through the resistance trend line at $0.28 will initially point to a quick declining speed. Short-term traders are anticipated to see a retreat of -26.98% over the course of a quarter and, with 90% chance the price will be floating in the range of $0.20 and $0.30 in this timeframe.

Argos Therapeutics, Inc. Technical Signals

ARGS has witnessed its long term and short term MA triggering a sell signal. Many traders watch for long-term averages to cross above short-term averages to signal the beginning of a downtrend. Upon corrections, the price will meet resistance from the averages between $0.32 and $0.38. A buy signal will be generated if it crosses above any of these levels. Its pivot point high generated sell signal on Wednesday June 21, 2017, which calls for additional declines until the stock forms a new pivot point low, as this could be a buying opportunity. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Argos Therapeutics, Inc. (NASDAQ:ARGS) Support And Resistance Levels

There is no support from accumulated volume below today’s level and given the right condition the stock may perform very badly in the next couple of days. In case of gains, the next resistance from accumulated volume will be at $0.36, $0.36 and $0.34.

Argos Therapeutics, Inc. (ARGS) Risk Assessment

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be high risk. In the most recent session, the stock price hovered around $0.02 between high and low, or 8.39%. For the last week the stock has had a daily average volatility of 9.34%.

Argos Therapeutics is in oversold territory based on Relative Strength Index reading (16). In some cases it takes more time for the trend to shift while the stock is being oversold and the Relative Strength Index keeps moving.


Previous ArticleNext Article

Related Post

GoPro, Inc. (GPRO) Internals Are Exhibiting Confli... GoPro, Inc. (NASDAQ:GPRO) gained 1.42% in Friday’s session, going up from its prior closing price of $9.86 to $10.00, and has now recorded rally in 4 ...
SM Energy Company (SM) vs. Anworth Mortgage Asset ... SM Energy Company (NYSE:SM) shares are up more than 14.49% this year and recently increased 2.56% or $0.63 to settle at $25.28. Anworth Mortgage Asset...
Comparing Valuation And Performance: Office Depot,...   The shares of Office Depot, Inc. have decreased by more than -30.51% this year alone. The shares recently went down by -3.53% or -$0.09 and ...
Medtronic plc (MDT) vs. Glaukos Corporation (GKOS)... Medtronic plc (NYSE:MDT) and Glaukos Corporation (NYSE:GKOS) are the two most active stocks in the Medical Appliances & Equipment industry based o...
Turtle Beach Corporation (HEAR) and Platinum Group... Turtle Beach Corporation (NASDAQ:HEAR) shares are up more than 744.92% this year and recently decreased -4.25% or -$0.68 to settle at $15.31. Platinum...

Leave a Reply

Your email address will not be published.